Tag: Pharma

The company has launched Enzyme Replacement Therapy bouquet for Lysosomal Storage Disorders (LSD), Idursulfase for Hunter Syndrome, Velaglucerase Alpha for Gaucher Disease and Agalsidase Alfa for Fabry Disease..........................

STARLIMS QM 12.0 is designed for the global manufacturing and R&D sectors including pharmaceuticals/biotech, chemicals and petrochemicals, oil and gas, food and beverage, contract services, consumer products and general manufacturing................

The enhanced capability opens the Michigan site up to a new base of customers, including the antibody drug conjugate (ADC) market.............................

Over 200 thought leaders from across India were involved in formulating the protocols of practice on endometriosis after a national meeting in Mumbai followed by regional meetings in major cities......................

Total Agilent Experience has fast become the place to be for professionals from chemical, food and pharma industries over the years, drawing over 300 scientists and researchers from across the country....................

As the pharmaceutical packaging sector is likely to witness substantial growth in the future, there are certain factors on which the market is foreseen to bank upon for its development...................

While the company recorded the year on year revenue growth up to 21 percent standing ar Rs 9,111 crore and EBITDA up by 14% to Rs 1,775 crore. The normalized PAT stood at Rs 855 crore. During the fourth quarter, revenue was Rs 2,386 crore and normalized PAT was at Rs 135 Crore................

Potapov’s appointment follows Takeda’s recent acquisition of Shire Pharmaceuticals – enabling Takeda to become a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan...............

In her role at Cipla, Raju will oversee Human Resources, and Administration and Facilities Management......................

Jamia Hamdard, New Delhi in collaboration with CSIR-IIIM Jammu organized a session on ‘Phytopharmaceuticals: Development, Regulatory, IPR & Marketing Challenges’..................